How to choose the best AI platform for healthcare?
Choose a healthcare AI platform like a clinical intervention: decide the specific use and the outcome you want to move; demand evidence from prospective studies in a population like yours rather than accuracy figures on the vendor's data; check which functions are actually regulated; audit performance across patient subgroups in your own population; test the workflow and alert burden with your clinicians; read the data governance terms; and set up local monitoring and a way to switch it off before going live.
Choose an AI platform for healthcare the way you would adopt any clinical intervention — by the outcome it changes and the evidence it changes it — and the criteria rank in that order. First: define the clinical use case and the outcome measure before seeing a demo, because a platform sold as 'AI for healthcare' does many things and each must be judged separately. Second: demand prospective and external validation in a population like yours, since retrospective AUROC on the vendor's data is the norm and predicts little (of 81 deep-learning-versus-clinician studies, 9 were prospective and 6 ran in real clinical settings). Third: check regulatory status per use — which functions are cleared devices, which are 'clinical decision support' outside regulation, which are administrative — and treat clearance as a floor. Fourth: audit bias and equity with subgroup performance in your population, because the field's documented case, a care-management algorithm whose correction would have raised the share of Black patients receiving extra help from 17.7% to 46.5%, was a widely deployed commercial product. Fifth: test workflow integration and alert burden with your own clinicians, since alert fatigue kills more deployments than inaccuracy. Sixth: review data governance — where data go, whether they train the vendor's models, what happens at contract end. Seventh: set up local performance monitoring and a kill switch before go-live, because models drift and populations change. The vendor who welcomes every one of these questions is the one to shortlist.
- Buy an outcome, not a platform; each function is a separate clinical intervention with its own evidence.
- Retrospective accuracy on vendor data is the default evidence and is nearly worthless for procurement.
- Clearance is per function and is a floor; decision-support features often sit outside regulation entirely.
- Bias is measured in deployment, not asserted in a brochure; audit subgroups in your own population.
- Local monitoring with a defined kill switch is not optional; models drift and the vendor will not tell you.
The criteria, ranked in the order a clinician would apply them
Ranked on: how much each criterion determines whether the platform improves an outcome in your setting, and how often skipping it has caused a failed or harmful deployment.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | 1. Define the use case and the outcome measure | Decides what evidence is even relevant | GRADE AEstablished |
| 2 | 2. Demand prospective, external validation in a population like yours | Separates evidence from marketing | GRADE AEstablished |
| 3 | 3. Check regulatory status per function | A floor, and only where it applies | GRADE AEstablished |
| 4 | 4. Audit bias and equity in your population | Measured, not asserted | GRADE AEstablished |
| 5 | 5. Test workflow integration and alert burden | Alert fatigue kills more deployments than inaccuracy | GRADE BPromising |
| 6 | 6. Review data governance | Who owns what, and for how long | GRADE BPromising |
| 7 | 7. Set up local monitoring and a kill switch | Models drift; populations change | GRADE BPromising |
- 01
1. Define the use case and the outcome measure
GRADE AEstablishedDecides what evidence is even relevant'Reduce time to thrombectomy', 'raise adenoma detection', 'cut heart-failure readmissions', 'reduce documentation time by X minutes'. One function, one outcome, one measurement plan. A platform pitch that cannot be reduced to such sentences is not ready for procurement.
- 02
2. Demand prospective, external validation in a population like yours
GRADE AEstablishedSeparates evidence from marketingRetrospective AUROC on the vendor's dataset is level 1 and is what almost every product has. Ask for prospective studies, external validation at sites unlike the development site, and randomised trials where they exist (mammography, colonoscopy). If none exist, the deployment is a study and should be governed as one.
- 03
3. Check regulatory status per function
GRADE AEstablishedA floor, and only where it appliesWhich functions are cleared or approved devices, for what indication and population; which are 'clinical decision support' that regulators exempt; which are administrative. Clearance certifies task performance, not benefit. An uncleared function making clinical suggestions is your liability.
- 04
4. Audit bias and equity in your population
GRADE AEstablishedMeasured, not assertedSubgroup performance by sex, ethnicity, age, language and deprivation, in your data, before go-live and on a schedule after. The AI section's documented case — a commercial care-management algorithm that used cost as a proxy for need and under-served Black patients by a wide margin — was deployed at scale before anyone looked. Ask the vendor for subgroup metrics and run your own.
- 05
5. Test workflow integration and alert burden
GRADE BPromisingAlert fatigue kills more deployments than inaccuracyPilot with your clinicians in the real EHR: alerts per clinician per day, override rate, time added or saved, where the output appears. A sepsis model that fires on a third of admissions will be ignored within a month regardless of its AUROC.
- 06
6. Review data governance
GRADE BPromisingWho owns what, and for how longWhere patient data are processed and stored, whether they train the vendor's models, de-identification standards, sub-processors, breach terms, and data return or destruction at contract end. Health data used to train a commercial model is a transfer of value the contract should price or prohibit.
- 07
7. Set up local monitoring and a kill switch
GRADE BPromisingModels drift; populations changePerformance dashboards on your own outcomes, drift detection, a named clinical owner, a review cadence, and a documented procedure to switch the function off. The vendor's model updates should trigger re-validation. This is pharmacovigilance for algorithms.
The questions that expose a platform
What to ask, and what the answers mean
| Question | Strong answer | Weak answer |
|---|---|---|
| What outcome does this function change, and in which study? | Named outcome, prospective study, effect size | 'Improves efficiency and outcomes' |
| Where was it validated outside your development data? | Named external sites with published results | 'Validated on millions of records' |
| Which functions are cleared devices, and for what indication? | A list, with clearance numbers | 'Our platform is FDA-compliant' |
| Show subgroup performance by ethnicity, sex and age | Tables provided; support for a local audit | 'Our model is bias-free' |
| What is the alert rate per clinician per day at a comparable site? | A number, with override rates | 'Configurable' |
| Do our patient data train your models? | No, or priced and consented | 'We use aggregated data to improve the product' |
| How do we monitor drift and switch it off? | Dashboards, drift alerts, documented kill switch | 'We monitor performance centrally' |
| Who is clinically accountable for an error? | A defined shared model in the contract | Silence |
Frequently asked questions
How do I choose the best AI platform for healthcare?
As you would adopt a clinical intervention, in order: define the use case and outcome measure; demand prospective and external validation in a population like yours; check regulatory status per function; audit bias and equity in your own data; pilot workflow integration and alert burden with your clinicians; review data governance; and set up local performance monitoring with a kill switch before go-live.
What evidence should a healthcare AI vendor provide?
Prospective studies in real clinical settings, external validation at sites unlike the development site, and randomised trials where they exist. Retrospective accuracy on the vendor's own data is level-1 evidence and is what nearly every product has; of 81 deep-learning-versus-clinician studies, only 9 were prospective and 6 ran in real clinical settings. If no prospective evidence exists, the deployment is a study and should be governed as one.
Does FDA clearance make a healthcare AI platform safe to adopt?
Clearance certifies performance on a defined task against a reference standard, for a specified indication and population; it is a floor, not evidence of benefit, and it applies function by function. Many decision-support features sit outside regulation entirely. Ask which functions are cleared, for what, and treat the rest as your liability.
How do I check a healthcare AI platform for bias?
Ask the vendor for subgroup performance by sex, ethnicity, age, language and deprivation, then run the same audit on your own data before go-live and on a schedule afterwards. The documented case in the field — a widely deployed care-management algorithm whose correction would have raised the share of Black patients receiving extra help from 17.7% to 46.5% — shows that bias is found by looking, not by asking.
Why do healthcare AI deployments fail?
Most often from alert fatigue and workflow friction rather than inaccuracy: a model that fires too often or in the wrong place is ignored within weeks. Other causes are drift after go-live with no local monitoring, poor external validity, and clinicians who were never involved in the pilot. Each is preventable by the criteria above.
What should the data clause in a healthcare AI contract say?
Where data are processed and stored; whether patient data train the vendor's models and, if so, under what consent and at what price; de-identification standards; named sub-processors; breach notification terms; and return or destruction of data at contract end. Data used to train a commercial model are a transfer of value; the contract should recognise that.
Keep reading
- AI-powered health forecasting
The evidence levels, the prospective-study counts and the documented bias case.
- AI health analytics software for hospitals and clinics.
The analytics functions ranked by evidence.
- Comprehensive AI health solution for remote patient monitoring.
One function specified properly, layer by layer.
- How we grade evidence
The grading behind every ranking on the site.
More in AI health tools
- What is the best AI tool for health tracking?
FDA-cleared cardiac algorithms on major smartwatches — irregular-rhythm notification and single-lead ECG — rank first, validated; chatbots rank last.
- Which AI health app helps monitor chronic conditions?
Diabetes and hypertension apps that connect glucose or blood-pressure readings to a clinician who titrates treatment have the best evidence among these apps.
- How to choose the best AI health assistant?
Choosing an AI health assistant starts with defining its job — information, triage, tracking or coaching — since none are licensed for actual medical advice.
- Which AI health platform offers personalized wellness recommendations?
Clinician-reviewed biomarker platforms that set a measured target, like ApoB, rank as the most genuinely personalized wellness AI, ahead of wearables.
- What AI health solution supports early disease detection?
AI-supported mammography has the strongest evidence of any AI in medicine, a 105,934-woman trial, ranking above colonoscopy AI and unproven consumer detection.
- Best AI health assistant for personalized diet and exercise.
AI programmes with human coaching, like Noom and Omada, rank first for weight-loss and diabetes-prevention trial evidence; chatbot meal plans rank last.